Semax (10mg)
$46.99
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment, modified with a C-terminal Pro-Gly-Pro extension to enhance metabolic stability and CNS activity. In research settings, Semax is studied for its interactions with neurotrophin signaling pathways, BDNF expression modulation, and neuroprotective mechanisms in central nervous system models.
BioRhex supplies Semax as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- COA-verified
- In stock
- ≥99% purity.
- USA manufactured.
What Is Semax?
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment, modified with a C-terminal Pro-Gly-Pro extension to enhance metabolic stability and CNS activity. In research settings, Semax is studied for its interactions with neurotrophin signaling pathways, BDNF expression modulation, and neuroprotective mechanisms in central nervous system models.
BioRhex supplies Semax as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Compound Overview
Semax is a neuropeptide analogue studied for its neurological signaling properties. In vitro and preclinical research models examine how Semax may influence:
• BDNF and NGF expression modulation in neuronal cell models
• Melanocortin receptor interactions in CNS tissue research
• Neuroinflammatory signaling and cytokine pathway modulation
• Dopaminergic and serotonergic system interactions in preclinical models
• Synaptic plasticity and cognitive pathway signaling research
All findings referenced are from controlled research environments and do not represent clinical outcomes or therapeutic claims.
History of Semax
Semax was developed at the Institute of Molecular Genetics in Moscow by Nikolai Myasoedov and colleagues during research into neuroprotective ACTH analogues. The C-terminal Pro-Gly-Pro addition was found to significantly extend biological activity compared to the parent ACTH(4-7) fragment.
Research into Semax’s neurological activity revealed interactions with BDNF pathway signaling and neurotrophin expression in CNS models, expanding its use as a tool in neuropharmacology research.
It remains a research compound of active interest in neurocognitive signaling, neuropeptide pharmacology, and neuroinflammatory pathway biology within controlled laboratory environments.
Molecular Structure
Met-Glu-His-Phe-Pro-Gly-Pro
Research Findings
Published and preclinical research on Semax covers several areas of scientific investigation, including:
BDNF signaling research: Studies examine how Semax modulates BDNF expression and TrkB receptor pathway activity in neuronal cell models.
Neuroprotective mechanism modeling: Research investigates Semax’s interactions with oxidative stress and neuroinflammatory mediators in CNS tissue models.
Melanocortin CNS pharmacology: Laboratory studies explore Semax’s receptor interactions and downstream signaling in neural models.
Synaptic pathway research: Preclinical models examine Semax’s effects on synaptic signaling and neuroplasticity-associated markers.
All findings referenced are from controlled, non-clinical research models and do not imply therapeutic or clinical application.
References
FAQ
Q: What type of research is Semax used for?
Q: What type of research is Semax used for?
A: Semax is used in laboratory research settings. All supplied compounds are intended strictly for in vitro and preclinical research purposes. Use is limited to controlled scientific environments.
Q: Where is BioRhex’s Semax manufactured?
Q: Where is BioRhex’s Semax manufactured?
A: All BioRhex compounds, including Semax, are manufactured in a GMP-compliant facility located in the United States.
Q: What testing does BioRhex conduct on Semax?
Q: What testing does BioRhex conduct on Semax?
A: Every batch of Semax undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. A Certificate of Analysis is included with every order, documenting batch-specific purity data at a ≥99% threshold.
Q: Is Semax approved for human use?
Q: Is Semax approved for human use?
A: No. Semax is not FDA-approved and is not intended for human or animal administration. It is supplied exclusively for laboratory research purposes.
Q: Who should handle this compound?
Q: Who should handle this compound?
A: Only qualified personnel in controlled laboratory settings following appropriate safety and handling protocols.
Research Use Only
All BioRhex compounds are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, or therapeutic application. Retatrutide is not FDA-approved for any medical purpose. Nothing on this page should be interpreted as health guidance or applied outside controlled research settings.
RELATED PRODUCTS
AOD9604 (5mg)
BPC-157
BPC-157 + TB-500
CJC (no DAC) + Ipamorelin (10mg)
